Midarine (Suxamethonium Chloride)

Midarine, a depolarizing neuromuscular blocking agent, is used in clinical situations that require rapid skeletal muscle relaxation.

• Facilitation of tracheal intubation: provides quick muscle relaxation to allow safe airway placement.
• Induction of skeletal muscle relaxation for surgery: creates temporary paralysis to improve surgical conditions.
• Adjunct to general anesthesia: enhances anesthetic depth and prevents patient movement.
• Facilitation of mechanical ventilation: enables controlled ventilation in intensive care settings.

• Suxamethonium chloride acts as an agonist at nicotinic acetylcholine receptors on the motor end‑plate. It binds and depolarizes the membrane, producing an initial contraction followed by sustained depolarization that renders the muscle fiber unresponsive to further stimulation, resulting in temporary paralysis. The drug is then rapidly hydrolyzed by plasma cholinesterase, terminating the block.

Administration of suxamethonium chloride may be associated with a range of adverse reactions, varying from transient to serious.

Common Side Effects

• Hyperkalemia: transient rise in serum potassium levels.
• Flushing or erythema: mild skin reddening.
• Muscle pain or fasciculations: brief involuntary contractions.
• Tachycardia: temporary increase in heart rate.

Serious or Rare Side Effects

• Malignant hyperthermia: life‑threatening hypermetabolic reaction.
• Prolonged apnea: extended respiratory paralysis requiring ventilation.
• Severe cardiac arrhythmias: potentially dangerous heart rhythm disturbances.
• Anaphylaxis: acute allergic reaction with airway compromise.

Prior to using Midarine, several safety considerations should be evaluated to minimize risk.

• Assess patient history: check for known susceptibility to malignant hyperthermia or atypical plasma cholinesterase.
• Monitor neuromuscular function: use peripheral nerve stimulator during and after administration.
• Avoid in hyperkalemic patients: risk of exacerbating elevated potassium levels.
• Use cautiously in cardiac disease: potential for arrhythmias and tachycardia.
• Store at controlled room temperature: keep in original packaging, protect from light and moisture.

Midarine can interact with other medicines, influencing the depth and duration of neuromuscular blockade.

Major Interactions (Avoid)

• Atypical plasma cholinesterase inhibitors (e.g., echothiophate): may prolong paralysis.
• Potassium‑raising agents (e.g., potassium chloride): increase risk of severe hyperkalemia.
• Volatile anesthetics that depress neuromuscular transmission: additive muscle‑relaxant effect.

Moderate Interactions (Monitor Closely)

• Anticholinesterases used for reversal (e.g., neostigmine): can cause paradoxical weakness if given too early.
• Magnesium sulfate: may potentiate the neuromuscular block.
• Calcium channel blockers: can enhance the depth of paralysis.